All terms in DRUGBANK

Label Id Description
Deoxy-2-fluoro-beta-D-cellotrioside DB01633
Tranexamic acid DB00302 [Antifibrinolytic hemostatic used in severe hemorrhage.]
Rhamnose DB02961 [A methylpentose whose L- isomer is found naturally in many plant glycosides and some gram-negative bacterial lipopolysaccharides. [PubChem]]
Benzimidazole DB02962
Flucloxacillin DB00301 [Antibiotic analog of [cloxacillin].]
5-O-phosphono-alpha-D-ribofuranosyl diphosphate DB01632 [The key substance in the biosynthesis of histidine, tryptophan, and purine and pyrimidine nucleotides.]
1-Carboxyethylaminomethyl-4-Aminomethylbenzene DB02960
Quahog, unspecified DB11009 [Quahog, unspecified allergenic extract is used in allergenic testing.]
Poultry DB11008 [Poultry allergenic extract is used in allergenic testing.]
Cytisus scoparius flowering top DB11007 [Cytisus scoparius flowering top allergenic extract is used in allergenic testing.]
Parkinsonia florida pollen DB11006 [Parkinsonia florida pollen allergenic extract is used in allergenic testing.]
N-acetylsulfanilyl chloride DB12337 [ASC has been investigated for the screening of Patients Undergoing Screening or Surveillance Colonoscopy.]
Ipidacrine DB13668
Human interferon beta DB14999 [Human interferon beta is under investigation in clinical trial NCT02584829 (Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma).]
Morpholine DB13669
Carisbamate DB12338 [Carisbamate has been investigated in Alcohol Abuse, Substance Abuse, and Alcohol Dependence.]
Radezolid DB12339 [Radezolid has been used in trials studying the treatment of Abscess, Bacterial Skin Diseases, Streptococcal Infections, Infectious Skin Diseases, and Staphylococcal Skin Infections, among others.]
SPK-843 DB12333 [SPK-843 has been used in trials studying the treatment of Cryptococcosis or Aspergillosis Infections.]
Formocortal DB13664
Sutimlimab DB14996 [Sutimlimab is under investigation in clinical trial NCT03347422 (A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Without A Recent History of Blood Transfusion (Cadenza Study)).]